Literature DB >> 3610448

Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms.

I Persson, L Bergkvist, H O Adami.   

Abstract

A questionnaire study conducted in a cohort of women who had been prescribed oestrogen treatment for climacteric symptoms provided a unique opportunity to assess the concordance between their histories of oestrogen use and the exposure data derived from the prescription forms that had been collected for recruitment of the cohort. The questionnaire information, which was gathered within three years after the registration of prescription forms, was found to be highly concordant with the prescription data with respect to name of brand (85%), dosage (88%), treatment schedule--cyclic versus continuous--(88%), total duration of drug intake (months of treatment; correlation coefficient 0.98) and time of start of medication (correct month in 85%). A method for estimating the true exposure on the basis of prescription data--taking into account non-compliance and non-registered forms--was developed and found to be reproducible. It was concluded that information on climacteric oestrogen intake could be reliably obtained through a questionnaire within a period of less than three years after the exposure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610448     DOI: 10.1093/ije/16.2.222

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  5 in total

1.  Noncontraceptive hormone use and risk of breast cancer.

Authors:  C P Yang; J R Daling; P R Band; R P Gallagher; E White; N S Weiss
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

2.  Validity of Self-Reported Medication Use Compared With Pharmacy Records in a Cohort of Older Women: Findings From the Women's Health Initiative.

Authors:  Rebecca L Drieling; Andrea Z LaCroix; Shirley A A Beresford; Denise M Boudreau; Charles Kooperberg; Susan R Heckbert
Journal:  Am J Epidemiol       Date:  2016-07-07       Impact factor: 4.897

3.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.

Authors:  I Persson; H O Adami; L Bergkvist; A Lindgren; B Pettersson; R Hoover; C Schairer
Journal:  BMJ       Date:  1989-01-21

4.  Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.

Authors:  Lena U Rosenberg; Cecilia Magnusson; Emma Lindström; Sara Wedrén; Per Hall; Paul W Dickman
Journal:  Breast Cancer Res       Date:  2006-02-17       Impact factor: 6.466

5.  Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.

Authors:  Marit Waaseth; Kjersti Bakken; Vanessa Dumeaux; Karina S Olsen; Charlotta Rylander; Yngve Figenschau; Eiliv Lund
Journal:  BMC Womens Health       Date:  2008-01-14       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.